Which contraception options are generally considered safe for cancer survivors, depending on cancer type?

• A. All hormonal methods are safe
• B. Nonhormonal methods (e.g., copper IUD, condoms) and carefully selected progestin-containing methods after medical consultation.
• C. Only condoms are safe
• D. None are safe; fertility preservation required

Answer: (B)

The main idea is that contraception for cancer survivors must be tailored to the cancer type and treatment, because hormones can influence some tumors. Estrogen-containing methods are often avoided in cancers that are hormone-sensitive, so safe options are those that do not introduce systemic hormones or are used only after careful medical review.

Nonhormonal methods, such as the copper IUD and condoms, deliver highly effective contraception without introducing hormones, and they don’t interact with cancer treatments in most situations. The copper IUD provides long-acting, reversible contraception with no hormonal exposure, which is why it’s considered broadly safe for many cancer survivors. Condoms offer protection against sexually transmitted infections as well as pregnancy, adding another layer of safety. Together, these nonhormonal options form a reliable baseline for many patients.

There are scenarios where progestin-containing methods may be considered, but this requires individualized assessment. Progestins do not contain estrogen, which can be advantageous for some patients, but their safety can vary depending on cancer type and current treatment. Therefore, involving the oncology team to evaluate risks and benefits is essential before selecting a hormonal method.

The other choices imply blanket safety for all hormonal methods or that none are safe, which isn’t accurate. Hormonal contraception can be inappropriate for some cancers but may be acceptable in others under medical guidance, making careful, individualized consultation the key.